The Science and Medicine of Comprehensive Osteoporosis Management

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

November 5, 2008

Expiration Date:

November 5, 2010

Intended Audience:

• Family medicine specialists
• Bone metabolism experts
• Preventive medicine specialists
• Gynecologists
• Nurse practitioners
• Orthopedic surgeons
• Consulting pharmacists
• Internal medicine specialists
• Endocrinologists
• Women's health physicians
• Geriatric nurse practitioners
• Rheumatologists

Registration:

Enrollment for this course is complimentary, and clinicians are invited to view this CME-certified webcast and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from Novartis Pharmaceuticals.
 

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

This activity has been planned and implemented in ac cordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massa chusetts Medical School (UMMS) and CMEducation Re sources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

The UMMS designates this continuing medical education activity for a maximum of 2.5 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectiv ity and scientific rigor in all activities. All faculty partici­pating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relation ships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty:

Program Chairman and Moderator
Mone Zaidi, MD, PhD, FRCP, FACP
Professor of Medicine and Physiology
Director, Mount Sinai Bone Program
Mount Sinai School of Medicine
New York, NY

Felicia Cosman, MD
Clinical Director, National Osteoporosis Foundation
Medical Director of the Clinical Research Center
Helen Hayes Hospital
West Haverstraw, New York
Associate Professor of Clinical Medicine
Columbia University, New York

Anthony I. Sebba, MD, FACR
Assistant Clinical Professor
Department of Rheumatology
University of South Florida
Tampa, Florida

Faculty Disclosures:

Mone Zaidi, MD, PhD, FRCP
Grants/research support: Procter and Gamble Pharmaceuticals, IRIS (Paris) and Genzyme Corporation
Speaker's Bureau: Alliance for Better Bone Health, Procter and Gamble, sanofi-aventis Pharmaceuticals, Novartis, Merck, Roche, GlaxoSmithKline

Felicia Cosman, MD
Research/grant: Eli Lilly and Company
Consultant: Novartis Pharmaceuticals Corporation, Eli Lilly and Company, Merck & Co., Inc., Pfizer, and Roche
Speakers Bureau: Eli Lilly and Company, Merck & Co., Inc., and Roche

Anthony I. Sebba, MD, FACR
Clinical Research, Speaker Panel or Advisory Boards: Amgen, Novartis, Merck, Roche, GSK and Lilly Pharmaceuticals

Educational Objectives:

Participants will:

• Learn to risk stratify patients at risk for osteoporosis and/or related complications and identify optimal therapeutic approaches.

• Learn to undertake a systematic evaluation of patients at risk for osteoporosis, including radiological exami nation and appropriate laboratory markers.

• Learn evidence-based approaches to reducing progression of osteoporosis, and reducing risk of fracture complications.

• Learn how to select safe and effective pharmaco therapy for prevention and treatment of postmeno pausal osteoporosis.

• Learn how landmark trials and analyses focusing on BMD, bisphosphonate therapy, predictive risk, and fracture reduction should guide clinical management of patients with osteoporosis

Disclaimer:

Copyright © 2008 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2008 All rights reserved